flesinoxan has been researched along with Depressive Disorder in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diksic, M; Skelin, I; Yamane, F | 1 |
Kenis, G; Kim, YK; Kubera, M; LasoĊ, W; Maes, M | 1 |
Bradford, D; Grof, P; Joffe, R; Kennedy, S; Persad, E; Syrotiuk, J | 1 |
Ansseau, M; Gonzalez Moreno, A; Hansenne, M; Pitchot, W | 1 |
Ansseau, M; Gonzalez Moreno, A; Hansenne, M; Jammaer, R; Lembreghts, M; Papart, P; Pitchot, W; Reel, C; Sulon, J; Wauthy, J | 1 |
Cryan, JF; Kelly, JP; Leonard, BE; Redmond, AM | 1 |
Ansseau, M; Hansenne, M; Machurot, PY; Moreno, AG; Pitchot, W; Reggers, J | 1 |
Ansseau, M; Herrera, C; Pitchot, W | 1 |
3 trial(s) available for flesinoxan and Depressive Disorder
Article | Year |
---|---|
Responses to mCPP stimulation in depressed patients.
Topics: Depressive Disorder; Double-Blind Method; Growth Hormone; Humans; Hydrocortisone; Male; Piperazines; Prolactin; Receptors, Serotonin; Serotonin Receptor Agonists | 1995 |
The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior.
Topics: Adult; Body Temperature; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Hormones; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Receptors, Serotonin; Serotonin Receptor Agonists; Suicide, Attempted | 1995 |
HPA axis dysfunction in major depression: relationship to 5-HT(1A) receptor activity.
Topics: Adrenocorticotropic Hormone; Adult; Body Temperature; Depressive Disorder; Dexamethasone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Piperazines; Prolactin; Psychiatric Status Rating Scales; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 2001 |
5 other study(ies) available for flesinoxan and Depressive Disorder
Article | Year |
---|---|
Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.
Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Binding, Competitive; Brain; Depressive Disorder; Down-Regulation; Drug Administration Schedule; Drug Interactions; Male; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission | 2008 |
Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fenclonine; Humans; Immunocompetence; Interleukin-6; Male; Middle Aged; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tumor Necrosis Factor-alpha | 2005 |
An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin | 1993 |
The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat.
Topics: Animals; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Male; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1997 |
Harm avoidance dimension of the Tridimensional Personality Questionnaire and serotonin-1A activity in depressed patients.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Personality Disorders; Piperazines; Prolactin; Radioimmunoassay; Serotonin; Serotonin Receptor Agonists; Surveys and Questionnaires | 1997 |